Abstract
The present research provides a theoretical investigation on applying pristine B3O3 nanosheet for sensory properties toward the ethyl butyrate biomarker to identify COVID-19 via exhaling breathing of lung-related diseases. This research shows that this nanostructure is an excellent substrate for the sense of ethyl butyrate biomarker, with energy adsorption in the range of −2.421 to −15.243 kcal/mol and desired recovery time 12.7 × 10-3 s. In addition to detecting COVID-19 from the patient's breath, this nanosheet can also deliver a Baricitinib drug to the target tissue to treat COVID-19. The interaction between carriers and drug indicates that adsorptions of the drug over B3O3 nanosheet are energetically favorable with energy adsorption in the range −5.788 to −40.009 kcal/mol in the gas phase −4.035 to −17.272 kcal/mol in water media with a significant percentage of changes in the band gap of the desired monolayer in considered systems. It is shown that Baricitinib can be released from the chosen carriers while apprising a weak external electric field of 0.001 and 0.002 eVÅ−1 e-1 in the opposite of y-direction. The drug/B3O3 complex reaction toward the external electric field is promising for developing efficient targeting drug delivery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
